One Down Two To GoBelow is a post I wrote on July 2nd. It indicated (after I had talked with the company) that we would be getting 3 main pieces of information "by mid-year" and that this was still (then) on-track.
Since that time, one of the 3 items has happened: The news on how they were going to fund the reMACE cardio trial. That news I think exceeded everyone's expectations.
That means we still have news coming regarding the potential Alzheimer's funding and about the diabetes trial results. Both pieces of news could come any day now...
There's also the potential of a Webcast in the near future from one or both companies. Management would not commit to that with me or give me a specific date - but I got the impression that a Webcast for both Zenith and one for RVX in the next several weeks was indeed the plan. My personal guess is that this will happen prior to the shareholder vote on August 13th.
Hopefully the rumoured Zenith Webcast will give specific details regarding the oft-rumoured Zenith IPO. That idea of an IPO has been floated around for quite a while now by various parties. I'd like to hear some specifics such as a date for that IPO as well as some supporting data to make it a success. ======================================
July 2nd Post
Mid-Year Clarification
A small update here on various items....
I talked with the company today to clarify a few things. First, they have indicated to me that "by-mid year" in their recent Q&A guideance did not mean strickly "by June 30th". Instead, it sounds like they are still on-track (from their viewpoint) for each of the following items:
1. Disclosure of diabetes results: It sounds to me that this information is on-track and they will be disclosing it soon to shareholders. Aparently they have a specific date in mind for this disclosure - although they won't of course share this at this time with anyone, myself included. To me, it sounds like we won't have to wait long to hear more.
2. Alzheimer's Disease Trial Funding: This information is also "on track" although that wording does not mean June 30th was the due date. They meant "by mid-year" more loosely. Sounds to me that we will hear about this soon, either way.
3. Funding for next cardio trial: This too is on track for disclosure "by mid-year" loosly speaking... thus, there is no change to their guideance on that. My own guess is that they will have something to announce soon.
Regarding the Zenith IPO: This is apparently still the plan. They hope to have more information to share with shareholders by the end of July.
It sounds like we will get a Webcast update soon for both companies... although they would not commit to this happening in July. That doesn't meant that it won't, it just means they won't verbally commit to that timing.
It might be a holiday week in Canada. Regardless, I was surprised this morning to find that my phone call was answered immediately. Sounds like they are very much working hard over at RVX.
I hear there's a stampede going on in Calgary. ENJOY to those who are there. That sounds like fun.
Read more at https://www.stockhouse.com/companies/bullboard/t.rvx/resverlogix-corp#aWv6qqSFQ9MSPofe.99